These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 1348713)

  • 1. Dopaminergic mechanisms in the pathogenesis of schizophrenia.
    Goldstein M; Deutch AY
    FASEB J; 1992 Apr; 6(7):2413-21. PubMed ID: 1348713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine receptor downregulation: an alternative strategy for schizophrenia treatment.
    Tsai SJ
    Med Hypotheses; 2004; 63(6):1047-50. PubMed ID: 15504573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A biochemical theory of schizophrenia].
    Kornhuber HH; Kornhuber J; Kim JS; Kornhuber ME
    Nervenarzt; 1984 Nov; 55(11):602-6. PubMed ID: 6151120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biochemistry of schizophrenia and mechanism of action of neuroleptics].
    Loo H; Cuche H; Sechter D
    Sem Hop; 1982 Dec; 58(44):2565-72. PubMed ID: 6130604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Schizophrenia.
    Bladessarini RJ
    N Engl J Med; 1977 Nov; 297(18):988-95. PubMed ID: 20577
    [No Abstract]   [Full Text] [Related]  

  • 6. Central dopaminergic mechanisms in schizophrenia.
    Owen F; Crow TJ; Poulter M
    Acta Psychiatr Belg; 1987; 87(5):552-65. PubMed ID: 2897760
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neurotensin, dopamine and mode of action of neuroleptics].
    Tassin JP
    Encephale; 1989; 15(5):465-70. PubMed ID: 2574102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholinergic aspects of schizophrenia.
    Tandon R
    Br J Psychiatry Suppl; 1999; (37):7-11. PubMed ID: 10211133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The mesencephalic dopaminergic system. Implications for neuroleptic treatment].
    Beaufils B
    Encephale; 1990; 16(3):167-74. PubMed ID: 1974842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antipsychotic drugs, neurotransmitters, and schizophrenia.
    Carlsson A
    Am J Psychiatry; 1978 Feb; 135(2):165-73. PubMed ID: 23684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuropharmacology of second-generation antipsychotic drugs: a validity of the serotonin-dopamine hypothesis.
    Kuroki T; Nagao N; Nakahara T
    Prog Brain Res; 2008; 172():199-212. PubMed ID: 18772034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopamine receptor signaling molecules are altered in elderly schizophrenic cortex.
    Baracskay KL; Haroutunian V; Meador-Woodruff JH
    Synapse; 2006 Sep; 60(4):271-9. PubMed ID: 16786528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The physiology, signaling, and pharmacology of dopamine receptors.
    Beaulieu JM; Gainetdinov RR
    Pharmacol Rev; 2011 Mar; 63(1):182-217. PubMed ID: 21303898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dopamine systems in the brain, functional classification of different dopamine receptors.
    Ljungberg T
    Acta Psychiatr Belg; 1987; 87(5):523-34. PubMed ID: 2897758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neuropathology of schizophrenia.
    Bachus SE; Kleinman JE
    J Clin Psychiatry; 1996; 57 Suppl 11():72-83. PubMed ID: 8941174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disruption of spine homeostasis causes dopaminergic compensatory up-regulation, resulting in schizophrenia.
    Sato K
    Med Hypotheses; 2012 Sep; 79(3):304-7. PubMed ID: 22683237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serotonin-dopamine interactions: implications for the design of novel therapeutic agents for psychiatric disorders.
    Wood MD; Wren PB
    Prog Brain Res; 2008; 172():213-30. PubMed ID: 18772035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diversity of dopamine receptors: new molecular and pharmacological developments.
    Hartman DS; Lanau F
    Pol J Pharmacol; 1997 Aug; 49(4):191-9. PubMed ID: 9437762
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin and dopamine interactions in rodents and primates: implications for psychosis and antipsychotic drug development.
    Marek GJ
    Int Rev Neurobiol; 2007; 78():165-92. PubMed ID: 17349861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The complexity of the dopaminergic synapses and their modulation by antipsychotics.
    Leuner K; Müller WE
    Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S15-20. PubMed ID: 16508891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.